SMAD signaling and airway cell fate determination
BACKGROUND: Goblet cell hyperplasia is a key feature of asthma and other airway diseases. It is likely regulated by the BMP/TGF-b/SMAD signaling pathway which is expressed in low levels in basal and goblet cells but highly active in other differentiated cell types. Therefore, SMAD signaling may b...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/42341 |